Total Payments
$118,989
2024 Payments
$24,507
Companies
78
Transactions
598
Medicare Patients
8,489
Medicare Billing
$864,623
Payment Breakdown by Category
Other$67,260 (56.5%)
Consulting$29,828 (25.1%)
Food & Beverage$15,017 (12.6%)
Travel$6,799 (5.7%)
Education$85.65 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $34,265 | 16 | 28.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,995 | 22 | 27.7% |
| Consulting Fee | $29,828 | 26 | 25.1% |
| Food and Beverage | $15,017 | 499 | 12.6% |
| Travel and Lodging | $6,799 | 22 | 5.7% |
| Education | $85.65 | 4 | 0.1% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$118,989
589 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROGEN PHARMA, INC. | $30,175 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $21,428 | 25 | $0 (2023) |
| SN Holdings, LLC | $16,560 | 24 | $0 (2024) |
| Olympus America Inc. | $12,854 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $10,911 | 44 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $7,672 | 27 | $0 (2024) |
| Verity Pharmaceuticals Inc. | $2,500 | 1 | $0 (2022) |
| Janssen Global Services, LLC | $2,020 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,205 | 4 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $840.87 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,507 | 108 | Janssen Biotech, Inc. ($9,319) |
| 2023 | $22,455 | 77 | UroGen Pharma, Inc. ($9,645) |
| 2022 | $24,767 | 100 | E.R. Squibb & Sons, L.L.C. ($14,021) |
| 2021 | $29,300 | 91 | SN Holdings, LLC ($7,854) |
| 2020 | $2,000 | 21 | Janssen Biotech, Inc. ($1,028) |
| 2019 | $5,415 | 65 | Olympus America Inc. ($3,772) |
| 2018 | $1,091 | 54 | Photocure Inc ($114.86) |
| 2017 | $9,453 | 82 | Olympus America Inc. ($7,949) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| 12/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $26.24 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | UROGEN PHARMA, INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/22/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: rezum_URO | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $817.50 | General |
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Urology Gynecology | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: HORMONE THERAPY | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| 10/28/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 10/24/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $79.71 | General |
| 10/24/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $48.87 | General |
| 10/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/14/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,268 | 6,996 | $877,055 | $199,071 |
| 2022 | 39 | 2,387 | 8,964 | $1.1M | $275,522 |
| 2021 | 28 | 1,862 | 6,247 | $659,693 | $166,989 |
| 2020 | 33 | 1,972 | 8,512 | $685,822 | $223,040 |
Total Patients
8,489
Total Services
30,719
Medicare Billing
$864,623
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 284 | 332 | $99,932 | $33,163 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 285 | $75,810 | $19,492 | 25.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 167 | 258 | $112,230 | $16,400 | 14.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 120 | $51,000 | $15,974 | 31.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 43 | 121 | $47,190 | $8,109 | 17.2% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 27 | 3,850 | $19,250 | $7,825 | 40.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 159 | 170 | $45,050 | $7,788 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 121 | $15,730 | $7,765 | 49.4% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 23 | 30 | $39,900 | $7,061 | 17.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 47 | $16,920 | $6,918 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 42 | $17,556 | $6,037 | 34.4% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 15 | 18 | $32,040 | $5,787 | 18.1% |
| A4648 | Tissue marker, implantable, any type, each | Office | 2023 | 12 | 14 | $6,696 | $4,958 | 74.0% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 23 | 25 | $14,125 | $4,879 | 34.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 13 | $66,820 | $4,470 | 6.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 106 | $13,992 | $4,347 | 31.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 41 | 69 | $11,454 | $3,684 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $10,000 | $3,077 | 30.8% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 36 | 36 | $14,796 | $2,721 | 18.4% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2023 | 11 | 12 | $8,340 | $2,677 | 32.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 25 | 26 | $14,950 | $2,482 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 31 | $9,331 | $2,428 | 26.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 16 | 17 | $10,540 | $2,180 | 20.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,903 | $2,082 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 34 | 37 | $9,842 | $2,073 | 21.1% |
About Dr. Rian Dickstein, MD
Dr. Rian Dickstein, MD is a Urology healthcare provider based in Hanover, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1407026487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rian Dickstein, MD has received a total of $118,989 in payments from pharmaceutical and medical device companies, with $24,507 received in 2024. These payments were reported across 598 transactions from 78 companies. The most common payment nature is "Honoraria" ($34,265).
As a Medicare-enrolled provider, Dickstein has provided services to 8,489 Medicare beneficiaries, totaling 30,719 services with total Medicare billing of $864,623. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Hanover, MD
- Active Since 03/06/2008
- Last Updated 05/27/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1407026487
Products in Payments
- JELMYTO (Drug) $23,561
- OPDIVO (Biological) $20,098
- Olympus Cysto-Resection (Device) $11,731
- ADSTILADRIN (Drug) $3,756
- ADSTILADRIN (Biological) $3,658
- Trelstar (Drug) $2,500
- ERLEADA (Drug) $1,650
- LYNPARZA (Drug) $1,098
- Single Use Repositionable Clip (Device) $740.00
- ORGOVYX (Drug) $593.84
- KEYTRUDA (Biological) $556.84
- Olympus Resection Disposables (Device) $538.94
- PYLARIFY (Drug) $514.44
- PROVENGE (Drug) $465.14
- GEMTESA (Drug) $459.84
- XIAFLEX (Biological) $452.64
- Nubeqa (Drug) $407.16
- ZEMDRI (PLAZOMICIN) (Drug) $370.58
- SONICBEAT 5 mm, 45 cm, Front-actuated Grip (Device) $362.60
- SpaceOAR VUE System - 10mL (Device) $323.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Hanover
Aisha Taylor, M.d, M.D
Urology — Payments: $29,193
Urology $29,193
Richard Jones, M.d, M.D
Urology — Payments: $1,083
Urology $1,083
Dr. Edward Leventhal, M.d, M.D
Urology — Payments: $754.00
Urology $754.00
Robert Tuliszewski, M.d, M.D
Urology — Payments: $59.58
Urology $59.58
William Bast, Md, MD
Urology
Urology